In the eMan Innovations fund, we invest in two to three new projects per year. The fund can also invest in projects from other technological sectors in 2023, if the investment committee decides.
Project Start 2022
Pharmacy Sector
The company Zenplanto focuses on the healthcare sector, specifically on the production of products and services related to hemp. Zenplanto manufactures its own range of CBD-containing hemp products, including dietary supplements, CBD cosmetics, and veterinary preparations with CBD content. Under the Zenplanto Farms brand, the company produces medicinal hemp in its own high-tech cultivation facility, ensuring the highest quality with a high THC content. All of Zenplanto’s production meets strict European Union standards. The company is also certified with Good Manufacturing Practice (GMP) certification.
Zenplanto manufactures its own range of CBD products. The production is fully in line with strict European Union standards. Zenplanto’s products meet rigorous Good Manufacturing Practice (GMP) certification.
The products do not contain dyes, pesticides, herbicides, toxins, or synthetic cannabinoids. In addition to wholesale distribution channels in the Czech Republic and Slovakia, sales are carried out through their own e-shop.
The Zenplanto Farms division produces medicinal hemp with a high THC content, utilizing its own state-of-the-art cultivation facility in Central Europe. In collaboration with specialists from the USA, a unique concept for a hi-tech cultivation facility was developed, faithfully mimicking the natural environment for optimal plant growth. The facility employs the latest specialized LED lighting that can simulate different seasons. Plants of specially bred hemp varieties with high THC content are cultivated. The production capacity is 1000 kg of dried material per year.
Zenplanto holds a license for the cultivation of hemp plants for medicinal use, issued by the State Institute for Drug Control (SUKL) in Prague on May 9, 2023 (sukl111849/2023). Zenplanto has been GMP certified for hemp cultivation since October 2023.
Project Start 2023
Pharmacy Sector
Senfina Labs is engaged in business activities in the field of drugstore and other fast-moving consumer goods. It supplies products to European Union countries and other nations. By utilizing advanced information technologies and artificial intelligence, the company has been successful in consistently negotiating the most favorable terms of cooperation, including prices. Its operations are continuously expanding, and the company is actively seeking new opportunities.
Project Start 2022
Energy Sector
The company MODULARITA focuses on the development, production, and sale of modular homes. Its innovative designs and technologies offer flexible solutions that meet a wide range of customer needs. It manufactures modular homes equipped with state-of-the-art technologies for energy efficiency and minimized environmental impact.
Speed and Efficiency
Because the modules are manufactured in a production facility, the construction of the house can progress concurrently with site preparation. This significantly shortens the construction time, typically within a few months.
Flexibility
Modular homes are like building blocks that can be tailored to specific needs. The basic module can be expanded at any time to accommodate changing customer requirements.
Sustainability
Modular construction minimizes waste and allows for more efficient use of materials. We emphasize the use of high-quality and environmentally friendly materials.
Project Start 2023
Energy Sector
ESTIS offers an innovative solution for the energy needs of municipalities and businesses through the development, deployment, and operation of an advanced information system for energy management. The key value lies in long-term energy sustainability, providing not only environmental but also financial benefits. ESTIS is prepared to take traditional energy solutions a step further, offering customers a favorable alternative to major players in the industry, such as ČEZ ESCO and E.ON, while building value for investors. The project presents a vision of stable dividend income and the potential for future sales.
U Pergamenky 1145/12
CZ-170 00 Prague 7
Czech Republic
The company is an alternative fund for qualified investors pursuant to Section 15 of Act No. 240/2013 Coll., on Investment Companies and Investment Funds, and only qualified investors may become its clients. The Company is subject to reporting to the ČNB, but is not subject to its supervision and regulation.
This website is for qualified investors only. If you are not a qualified investor according to Act No. 240/2013 Coll., please leave the site.